Omeros Corporation (NASDAQ:OMER) (MarketWatch)
Omeros Corp. OMER, +36.60% shares surged 45% in extremely heavy morning trade Thursday on a new government spending bill that benefits its cataract surgery drug Omidria. Omidria’s “pass-through” status with Medicare, which allows for a higher reimbursement rate, expired late last year, and the drug was expected to be bundled with other cataract surgery supplies, which might have forced Omeros to decrease the price “by up to 90 percent to remain competitive,” said Height analyst Andrea Harris.
AbbVie Inc (NYSE:ABBV) (The Motley Fool)
What happened: After the biotech giant’s disappointing update on an important experimental cancer drug, shares of AbbVie (NYSE:ABBV) fell as much as 12% in early morning trading on Thursday. Shares were down 11% as of 10:35 a.m. EDT. So what: The drug in question is called rovalpituzumab tesirine, which goes by the nickname Rova-T. AbbVie shared a little bit of data from a phase 2 trial today that was studying Rova-T as a third-line treatment for relapsed/refractory small-cell lung cancer.
lassedesignen/Shutterstock.com
Odyssey Marine Exploration Inc (NASDAQ:OMEX) (Benzinga)
Odyssey Marine Exploration, Inc. shares jumped 150.1 percent to $9.48 after the company disclosed positive Mexico Court Decision nullifying a previous denial of application for Don Diego project.
Darden Restaurants, Inc. (NYSE:DRI) (CNBC)
Darden Restaurants – The parent of Olive Garden and other restaurant chains came in 7 cents a share above estimates, with adjusted quarterly profit of $1.71 per share. It also increased its full-year outlook to a range that comes in mostly above current consensus. The most recent quarter’s revenue, however, did fall below analyst estimates.
Reckitt Benckiser Group Plc-ADR (OTCMKTS:RBGLY) (MarketWatch)
Reckitt Benckiser Group PLC shares RB., +4.78% surged 4.8% after the consumer goods company said it’s ending talks about its potential purchase of Pfizer Inc.’s PFE, -1.12% consumer health-care business. Reckitt Benckiser said it was looking to buy just part of the business, but that goal couldn’t be met.
Michaels Companies Inc (NASDAQ:MIK) (CNBC)
Michaels Companies – Michaels will shut its standalone Aaron Brothers stores, re-positioning the framing and arts supplies retailer as a “store within a store.” Separately, Michaels reported an inline quarter but issued a full-year forecast that’s somewhat short of analyst estimates.
Pandora Media Inc (NYSE:P) (MarketWatch)
Shares of Pandora Media Inc. P, +11.26% are up 5.9% in premarket trading Thursday after Raymond James analyst Justin Patterson upgraded the stock two notches, to strong buy from market perform. Patterson’s upgrade comes on the heels of Pandora’s announcement that it would be buying AdsWizz, an ad-tech platform that Patterson’s “back-of-the-envelope math” says could be worth about $4 a share. Patterson sees AdsWizz giving Pandora exposure to the $28 billion worldwide market for audio advertising and expanding the company’s reach.
Herman Miller, Inc. (NASDAQ:MLHR) (Benzinga)
Herman Miller, Inc. fell 9.4 percent to $33.80. Herman Miller reported upbeat results for its third quarter, but issued weak forecast for the fourth quarter.
Facebook, Inc. (NASDAQ:FB) (TheStreet)
Facebook Inc. (FB) shares fell for the third day in four Thursday after CEO Mark Zuckerberg broke his silence and apologised for the social media group’s data scandal and said he was open to the idea of tougher government oversight for the tech industry. Zuckerberg, who has faced criticism for his decision to wait several days to respond to allegations that a British media consultancy improperly gained access to 50 million Facebook users’ data and may have used it to sway the 2016 Presidential elections, issued a statement on the group’s public website, was interviewed in the New York Times and appeared on CNN in an effort to stem the flow of investors exiting the stock and ease pressure from regulators on both sides of the Atlantic.
